Supplementary Figure 3 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401684

2023-01-01

Abstract:PDF file - 141K, HIC1 and LCN2 do not affect epithelial-mesenchymal transition (EMT).

What problem does this paper attempt to address?

Supplementary Figure 2 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401687

2023-01-01

Abstract:PDF file - 131K, LCN2 does not affect ERK and NF-kB pathways.
Supplementary Figure 4 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401681

2023-01-01

Abstract:PDF file - 77K, LCN2 does not affect MMP9 expression.
Supplementary Figure 7 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401672

2023-01-01

Abstract:PDF file - 132K, LCN2 does not affect PTEN activity.
Supplementary Figure 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401690

2023-01-01

Abstract:PDF file - 623K, Effects of restoring HIC1 expression in MDA-468 cells.
Supplementary Figure 8 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401669.v1

2023-01-01

Abstract:PDF file - 344K, Endogenous HIC1 knockdown promotes cell migration and invasion in MCF-10A cells.
Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401678

2023-01-01

Abstract:PDF file - 570K, LCN2 promotes lung metastasis in balb/c nude mice.
Supplementary Table 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401657

2023-01-01

Abstract:PDF file - 116K, Correlation between expression of HIC1 and clinical pathological features in tissue microarrays.
Supplementary Table 2 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401654

2023-01-01

Abstract:PDF file - 118K, Serum levels of LCN2 in breast cancer patients.
Supplementary Figure 6 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401675

2023-01-01

Abstract:PDF file - 142K, The AKT signaling pathway is partly inactivated after NGALR knockdown.
Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.22527890

2023-01-01

Abstract:Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis
Supplementary Figure 2 from HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification

Jun Zheng,Jinglong Wang,Xueqing Sun,Mingang Hao,Tao Ding,Dan Xiong,Xiumin Wang,Yan Zhu,Gang Xiao,Guangcun Cheng,Mengmeng Zhao,Jian Zhang,Jianhua Wang

DOI: https://doi.org/10.1158/1078-0432.22450740

2023-01-01

Abstract:PDF file - 488K, Effects in PCa cells after knockdown of expression of HIC1
Supplementary Figure 3 from HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification

Jianghua Zheng,Jinglong Wang,Xueqing Sun,Mingang Hao,Tao Ding,Dan Xiong,Xiumin Wang,Yu Zhu,Gang Xiao,Guangcun Cheng,Meizhong Zhao,Jian Zhang,Jianhua Wang

DOI: https://doi.org/10.1158/1078-0432.22450737

2023-01-01

Abstract:PDF file - 904K, Restoring HIC1 expression prevents PCa metastasis by intracardiac and tail vein injections in BALB/c Nude mice
Supplementary Figures 1-6 from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

PengXu Qian,Arindam Banerjee,Zheng-Sheng Wu,Xiao Zhang,Hong Wang,Vijay Pandey,Wei-Jie Zhang,Xue-Fei Lv,Sheng Tan,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22395998

2023-01-01

Abstract:PDF file - 1291K, FIGURE S1: Representative data of genomic real-time PCR screening for DNA copy numbers of aberrant microRNAs on human chromosome 3p in breast carcinoma and the correlation between expression levels of miR-128 and ARPP21; FIGURE S2: miR-128 depletion confers non-tumorigenic MCF-10A cells with a malignant phenotype in vitro; FIGURE S3: Forced expression of miR-128 alters the morphology and reduces migration and invasion of MCF-7 cells in vitro, whereas miR-128 depletion confers non-tumorigenic HBL-100 cells with a malignant phenotype in vitro; FIGURE S4: miR-128 depletion confers a malignant phenotype on non-tumorigenic MCF-10A cells in vivo and miR-128 represses the CD44+CD24 Neg/Low population in mammary carcinoma cells; FIGURE S5: Interactions between miR-128 and its binding targets; FIGURE S6: Luciferase assay for promoter activity
Supplementary Figure 3 from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis

Li Qin,Ye-Lin Wu,Michael J. Toneff,Dabing Li,Lan Liao,Xiuhua Gao,Fiona T. Bane,Jean C.-Y. Tien,Yixiang Xu,Zhen Feng,Zhihui Yang,Yan Xu,Sarah M. Theissen,Yi Li,Leonie Young,Jianming Xu

DOI: https://doi.org/10.1158/0008-5472.22399163

2023-01-01

Abstract:PDF file - 72KB, Positive controls for transfection assays.
Supplementary Figure 1 from HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification

Jun Zheng,Jinglong Wang,Xueqing Sun,Mingang Hao,Tao Ding,Dan Xiong,Xiumin Wang,Yan Zhu,Gang Xiao,Guangcun Cheng,Mengmeng Zhao,Jian Zhang,Jianhua Wang

DOI: https://doi.org/10.1158/1078-0432.22450743.v1

2023-01-01

Abstract:PDF file - 416K, Methylation status of HIC1 promoter in plasma DNA from PCa patients and healthy controls.
Supplementary Table 2 from HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification

Jianghua Zheng,Jinglong Wang,Xueqing Sun,Mingang Hao,Tao Ding,Dan Xiong,Xiumin Wang,Yu Zhu,Gang Xiao,Guangcun Cheng,Meizhong Zhao,Jian Zhang,Jianhua Wang

DOI: https://doi.org/10.1158/1078-0432.22450716.v1

2023-01-01

Abstract:PDF file - 53K, Part of genes regulated more than 2-fold in PC3HIC1 and C4-2BHIC1 cells comparison with the control
Supplementary Figure 2 from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Jun Zhao,Mark Z. Ma,Hening Ren,Zhenqiu Liu,Martin J. Edelman,Hong Pan,Li Mao

DOI: https://doi.org/10.1158/1078-0432.22452492.v1

2023-01-01

Abstract:Supplementary Figure 2 - PDF file 693K, Notch intracellular domain IHC
Supplementary Figure 6 from linc00869 Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Xiaowen Shao,Yamei Dang,Tingting Zhang,Nan Bai,Jianing Huang,Mengya Guo,Li Sun,Minghe Li,Xiao Sun,Xinran Zhang,Feng Han,Ning Zhang,Hao Zhuang,Yongmei Li

DOI: https://doi.org/10.1158/1541-7786.25325135.v1

2024-01-01

Abstract:LINC00869 had no effect on the activity or expression of other cytoskeletal regulators.
Supplementary Figure 4 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Jianchao Zhang,Qian Liang,Yang Lei,Min Yao,Lili Li,Xiaoge Gao,Jingxin Feng,Yu Zhang,Hongwen Gao,Dong-Xu Liu,Jun Lu,Baiqu Huang

DOI: https://doi.org/10.1158/0008-5472.22393992.v1

2023-01-01

Abstract:PDF file - 1.8MB, SOX4 indirectly regulated E-cadherin transcription
Supplementary Figure 5 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Jianchao Zhang,Qian Liang,Yang Lei,Min Yao,Lili Li,Xiaoge Gao,Jingxin Feng,Yu Zhang,Hongwen Gao,Dong-Xu Liu,Jun Lu,Baiqu Huang

DOI: https://doi.org/10.1158/0008-5472.22393986

2023-01-01

Abstract:PDF file - 3.6MB, Silencing of SOX4 in MDA-MB-231 and BT549 cells inhibited their invasive ability

Supplementary Figure 3 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 2 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 4 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 7 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 8 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Table 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Table 2 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression through Misregulation of LCN2

Supplementary Figure 6 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figure 2 from HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification

Supplementary Figure 3 from HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification

Supplementary Figures 1-6 from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Supplementary Figure 3 from NCOA1 Directly Targets <i>M-CSF1</i> Expression to Promote Breast Cancer Metastasis

Supplementary Figure 1 from HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification

Supplementary Table 2 from HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification

Supplementary Figure 2 from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Supplementary Figure 6 from <i>linc00869</i> Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Supplementary Figure 4 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Supplementary Figure 5 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Supplementary Figure 3 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 2 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 4 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 7 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 8 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Table 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Table 2 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression through Misregulation of LCN2

Supplementary Figure 6 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figure 2 from HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification

Supplementary Figure 3 from HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification

Supplementary Figures 1-6 from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Supplementary Figure 3 from NCOA1 Directly Targets <i>M-CSF1</i> Expression to Promote Breast Cancer Metastasis

Supplementary Figure 1 from HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification

Supplementary Table 2 from HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification

Supplementary Figure 2 from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Supplementary Figure 6 from &lt;i&gt;linc00869&lt;/i&gt; Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Supplementary Figure 4 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Supplementary Figure 5 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Supplementary Figure 6 from <i>linc00869</i> Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation